ClinicalTrials.Veeva

Menu

Clinical & Radiographic Evaluation of Neo MTA Versus White MTA in Revascularization of Non-Vital Immature Permanent Teeth

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Early Phase 1

Conditions

Nonvital Tooth

Treatments

Biological: White MTA
Biological: NeoMTA nusmile

Study type

Interventional

Funder types

Other

Identifiers

NCT03545139
NeoMTA in Revascularization

Details and patient eligibility

About

  • To evaluate and compare the degree of tooth discoloration in tooth crowns induced by Neo MTA versus white MTA over time.
  • Evaluation of the effectiveness of Neo MTA as coronal plug in revascularization of immature teeth with necrotic pulp.

Full description

The new formulation of MTA (NeoMTA) does not contain bismuth oxide, will be used in revascularization of nonvital immature permanent anterior teeth.

to evaluate the effectiveness of Neo MTA as coronal plug and compare the degree of tooth discoloration in tooth crowns induced by Neo MTA versus white MTA over time.

Enrollment

30 estimated patients

Sex

All

Ages

7 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of patients: 7-15years old.
  • Free from any systemic diseases that may affect the normal healing process.
  • Tooth with immature root apex.
  • Traumatically or cariously exposed non vital permanent anterior tooth.
  • Pulp space not needed for post and core for final restoration.
  • Compliant patient/parent

Exclusion criteria

  • Patients having allergy to medicaments and antibiotics necessary to complete procedure.
  • Tooth with vital pulp or complete root formation.
  • Teeth with internal or external root resorption.
  • Un-cooperative patients.
  • Luxative injuries.
  • Teeth with a root fracture
  • Alveolar fracture
  • Subjects with chronic systemic illness.
  • Subjects with poor oral hygiene.
  • Compromised remaining tooth structure as teeth with extensive loss of coronal tissue will require restoration with a post that will occupy the space required for blood clot formation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

NeoMTA (intervention group)
Experimental group
Description:
Revascularization with NeoMTA as coronal plug.
Treatment:
Biological: NeoMTA nusmile
White MTA (Control group)
Active Comparator group
Description:
Revascularization with Conventional white mineral trioxide aggregate (White MTA) as coronal plug.
Treatment:
Biological: White MTA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems